You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PO007LBA/#1550  Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study

Alerts

Article menu

Download PDFPDF

Plenary 02: Changing the Landscape of Endometrial Cancer
AS04. Endometrial/Uterine corpus cancers
PO007LBA/#1550  Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address